Total Valuation
Navamedic ASA has a market cap or net worth of kr323.75M. The enterprise value is kr522.15.
Market Capkr323.75M
Enterprise Valuekr522.15
Share Statistics
Navamedic ASA has 23,981,379 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding23,981,379
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Navamedic ASA’s return on equity (ROE) is -0.07 and return on invested capital (ROIC) is 2.64%.
Return on Equity (ROE)-0.07
Return on Assets (ROA)-0.03
Return on Invested Capital (ROIC)2.64%
Return on Capital Employed (ROCE)0.03
Revenue Per Employee14.88M
Profits Per Employee-412.03K
Employee Count38
Asset Turnover0.76
Inventory Turnover3.23
Valuation Ratios
The current PE Ratio of Navamedic ASA is ―. Navamedic ASA’s PEG ratio is ―.
PE Ratio―
PS Ratio0.00
PB Ratio0.00
Price to Fair Value1.71
Price to FCF0.00
Price to Operating Cash Flow16.80
PEG Ratio―
Income Statement
In the last 12 months, Navamedic ASA had revenue of 565.36M and earned -23.54M in profits. Earnings per share was -0.98.
Revenue565.36M
Gross Profit188.97M
Operating Income16.25M
Pretax Income-15.66M
Net Income-23.54M
EBITDA47.61M
Earnings Per Share (EPS)-0.98
Cash Flow
In the last 12 months, operating cash flow was 19.21M and capital expenditures -2.55M, giving a free cash flow of 16.66M billion.
Operating Cash Flow19.21M
Free Cash Flow16.66M
Free Cash Flow per Share0.69
Dividends & Yields
Navamedic ASA pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-0.05
52-Week Price Change-45.44%
50-Day Moving Average16.33
200-Day Moving Average21.10
Relative Strength Index (RSI)2.84
Average Volume (3m)5.00
Important Dates
Navamedic ASA upcoming earnings date is Oct 29, 2026, TBA (Confirmed).
Last Earnings DateAug 14, 2026
Next Earnings DateOct 29, 2026
Ex-Dividend Date―
Financial Position
Navamedic ASA as a current ratio of 1.55, with Debt / Equity ratio of 59.79%
Current Ratio1.55
Quick Ratio0.89
Debt to Market Cap0.42
Net Debt to EBITDA3.22
Interest Coverage Ratio1.12
Taxes
In the past 12 months, Navamedic ASA has paid 7.88M in taxes.
Income Tax7.88M
Effective Tax Rate-0.50
Enterprise Valuation
Navamedic ASA EV to EBITDA ratio is 15.21, with an EV/FCF ratio of 31.20.
EV to Sales1.28
EV to EBITDA15.21
EV to Free Cash Flow31.20
EV to Operating Cash Flow28.30
Balance Sheet
Navamedic ASA has kr52.95M in cash and marketable securities with kr139.93M in debt, giving a net cash position of -kr130.05M billion.
Cash & Marketable Securitieskr52.95M
Total Debtkr139.93M
Net Cash-kr130.05M
Net Cash Per Share-kr5.42
Tangible Book Value Per Share-kr5.19
Margins
Gross margin is 29.75%, with operating margin of 2.87%, and net profit margin of -4.16%.
Gross Margin29.75%
Operating Margin2.87%
Pretax Margin-2.77%
Net Profit Margin-4.16%
EBITDA Margin8.42%
EBIT Margin2.87%
Analyst Forecast
The average price target for Navamedic ASA is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast9.69%
EPS Growth Forecast34.24%